Travere Therapeutics, Inc. (TVTX)
52.58
+0.28
(+0.54%)
USD |
NASDAQ |
Oct 21, 16:00
52.57
-0.01
(-0.02%)
After-Hours: 20:00
Travere Therapeutics Net Income (Annual) : -50.26M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -50.26M |
| December 31, 2024 | -320.63M |
| December 31, 2023 | -376.33M |
| December 31, 2022 | -331.47M |
| December 31, 2021 | -180.09M |
| December 31, 2020 | -169.43M |
| December 31, 2019 | -146.43M |
| December 31, 2018 | -102.68M |
| December 31, 2017 | -59.73M |
| Date | Value |
|---|---|
| December 31, 2016 | -47.90M |
| December 31, 2015 | 117.24M |
| December 31, 2014 | -110.94M |
| December 31, 2013 | -34.62M |
| December 31, 2012 | -30.34M |
| February 28, 2011 | -0.023M |
| February 28, 2010 | -0.028M |
| February 28, 2009 | -0.0183M |
| February 29, 2008 | -0.052M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| TG Therapeutics, Inc. | 447.18M |
| BioMarin Pharmaceutical, Inc. | 348.90M |
| Vertex Pharmaceuticals, Inc. | 3.953B |
| Viridian Therapeutics, Inc. | -281.93M |
| Krystal Biotech, Inc. | 204.83M |